Novartis brings on 8 business vets for Sandoz’s new board, including 4 women kdunleavy Mon, 05/15/2023 – 11:19 More: Novartis brings on 8 business vets for Sandoz's new board, including 4 women Source: fierce
read moreUPDATED: After Supreme Court rejection, Teva mulls options in GSK ‘skinny label’ feud fkansteiner Mon, 05/15/2023 – 10:59 More: UPDATED: After Supreme Court rejection, Teva mulls options in GSK 'skinny label' feud Source: fierce
read moreAfter Hemgenix approvals, uniQure cashes out some of its royalty rights for $375M-plus zbecker Mon, 05/15/2023 – 10:58 More: After Hemgenix approvals, uniQure cashes out some of its royalty rights for 5M-plus Source: fierce
read morePfizer, Seagen kick off antitrust review of $43B merger. Will FTC get on board? aliu Mon, 05/15/2023 – 10:03 More: Pfizer, Seagen kick off antitrust review of B merger. Will FTC get on board? Source: fierce
read moreWith NICE nod, Gilead clears another regulatory hurdle in Europe for Hepcludex kdunleavy Mon, 05/15/2023 – 09:30 More: With NICE nod, Gilead clears another regulatory hurdle in Europe for Hepcludex Source: fierce
read moreNICE’s decision will result in eligible patients using a treatment that slows or halts aspects of the illness More: NHS patients gain access to Gilead’s Hepcludex Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals